Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rozencweig

Showing results (51-60 of 150) with videos related to

Pageof 15
Sort By:
Bruxelles Medical|September 1, 1975
[Hodgkin's disease: a curable cancer]M Rozencweig, Y Kenis, J C Goffin, et al.
Surgery, Gynecology & Obstetrics|December 1, 1977
Peritoneoscopy as a diagnostic supplement to liver function tests and liver scan in patients with carcinomaH Bleiberg, M Rozencweig, E Longeval, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1981
Phase II study of oral VP-16-213 in hepatocellular carcinomaF Cavalli, M Rozencweig, J Renard, et al.
JAMA|October 11, 1976
Activity of daunomycin in solid tumorsD D Von Hoff, M Rozencweig, M Slavik, et al.
Cancer Treatment Reports|November 1, 1985
Clinical predictivity of transplantable tumor systems in the selection of new drugs for solid tumors: reply to a commentaryM J Staquet, D P Byar, S B Green, et al.
The New England Journal of Medicine|December 14, 1978
Sounding board. Waiting for a bus: Does it explain age-dependent differences in response to chemotherapy of early breast cancer?M Rozencweig, M Zelen, D D Von Hoff, et al.
Journal of Clinical Pharmacology|January 1, 1978
Double-blind crossover clinical pharmacology study comparing moxestrol (R 2858) and ethinyl estradiol in postmenopausal womenC Robyn, M Vekemans, M Rozencweig, et al.
Annals of Internal Medicine|June 1, 1977
Cis-diamminedichloroplatinum (II). A new anticancer drugM Rozencweig, D D von Hoff, M Slavik, et al.
Cancer|August 1, 1978
The chemotherapy of Hodgkin's disease: past experiences and future directionsV T DeVita, B J Lewis, M Rozencweig, et al.
Anticancer Research|January 1, 1981
Cisplatin: impact of a new anticancer agent on current therapeutic strategiesM Rozencweig, R Abele, D D von Hoff, et al.
Pageof 15

Showing results (51-60 of 150) with videos related to

Sort By:
Pageof 15
Bruxelles Medical|September 1, 1975
[Hodgkin's disease: a curable cancer]M Rozencweig, Y Kenis, J C Goffin, et al.
Surgery, Gynecology & Obstetrics|December 1, 1977
Peritoneoscopy as a diagnostic supplement to liver function tests and liver scan in patients with carcinomaH Bleiberg, M Rozencweig, E Longeval, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1981
Phase II study of oral VP-16-213 in hepatocellular carcinomaF Cavalli, M Rozencweig, J Renard, et al.
JAMA|October 11, 1976
Activity of daunomycin in solid tumorsD D Von Hoff, M Rozencweig, M Slavik, et al.
Cancer Treatment Reports|November 1, 1985
Clinical predictivity of transplantable tumor systems in the selection of new drugs for solid tumors: reply to a commentaryM J Staquet, D P Byar, S B Green, et al.
The New England Journal of Medicine|December 14, 1978
Sounding board. Waiting for a bus: Does it explain age-dependent differences in response to chemotherapy of early breast cancer?M Rozencweig, M Zelen, D D Von Hoff, et al.
Journal of Clinical Pharmacology|January 1, 1978
Double-blind crossover clinical pharmacology study comparing moxestrol (R 2858) and ethinyl estradiol in postmenopausal womenC Robyn, M Vekemans, M Rozencweig, et al.
Annals of Internal Medicine|June 1, 1977
Cis-diamminedichloroplatinum (II). A new anticancer drugM Rozencweig, D D von Hoff, M Slavik, et al.
Cancer|August 1, 1978
The chemotherapy of Hodgkin's disease: past experiences and future directionsV T DeVita, B J Lewis, M Rozencweig, et al.
Anticancer Research|January 1, 1981
Cisplatin: impact of a new anticancer agent on current therapeutic strategiesM Rozencweig, R Abele, D D von Hoff, et al.
Pageof 15